Insilico Medicine to present at Leveraging Intelligent Tech for Drug Development
Coronavirus: how the pharma industry is changing to produce a vaccine on time
Breaking COVID-19’s ‘clutch’ to stop its spread
Moderna Covid-19 vaccine appears safe, shows signs of working in older adults – study
CureVac plans global late-stage Covid-19 vaccine trial in Q4 2020
GSK CEO optimistic about Covid-19 vaccine in 2021
UK pledges £571m to equitable COVID-19 vaccine access scheme
Logos LP – Everything is F*cked
Roche Inks €380M Inflazome Deal, Boosting Inflammation Pipeline
Last-resort life support option helped majority of critically ill COVID-19 patients survive
FDA Approves Nucala as First Biologic Treatment for HES
Global Covid-19 death toll could hit 2 million before vaccine in wide use – WHO
Analyst: Don’t Say Buy Buy to Moderna Stock, Say Bye Bye
Japanese researchers trial early warning test for acute Covid-19 cases
3D printed nasal swabs work as well as commercial swabs for COVID-19 diagnostic testing
Madrid Expands Lockdown To More Than 1 Million People; Global COVID-19 Cases Top 32MN After Record Surge: Live Updates
BIOCAD will produce the COVID-19 vaccine developed by Gamalei Institute
White House Could Attempt to Overrule Potential New FDA Vaccine Guidance
W2O Acquires Elysia Group
UK gears up for ‘challenge trial’ of COVID-19 vaccine
Statins reduce COVID-19 severity, likely by removing cholesterol that virus uses to infect
UofA lab uncovers new mechanism of action against SARS-CoV-2 by antiviral drug remdesivir
FDA’s New Moves Can’t Allay Coronavirus Vaccine Fears
UK to host ‘human challenge’ trials for Covid-19 vaccines – FT
Fujifilm’s Avigan shown to be effective in Japanese Phase 3 trial for Covid-19
J&J’s One-Dose COVID-19 Vaccine Candidate Begins Phase III Trial
Coronavirus: the road to vaccine roll-out is always bumpy, as 20th-century pandemics show
Fourth large-scale COVID-19 vaccine trial begins in the United States
Tom-Tom Traffic Data Of Top US Metros Suggests "Sluggish" Recovery
U.S. health agency sets October 16 deadline for states to submit vaccine plans